MaxCyte Inc (MXCT)
US$ 00%
Price Chart
Key Statistics
Market Cap
$ 154.58M
P/E Ratio
0.00
Revenue (TTM)
$ 35.75M
Volume
0
52W High
$ 5.20
52W Low
$ 1.26
Dividend Yield
0.00%
Beta
0.29
Technicals
50-Day MA
1.7637
200-Day MA
2.9111
52 Week High
5.2
52 Week Low
1.26
About MXCT
MaxCyte, Inc., a life sciences company, discovers, develops, and commercializes cell therapeutics in the United States and internationally.
Employees
114
Headquarters
Rockville, MD
CEO
Mr. Maher Masoud
Latest News
MaxCyte (MXCT) Signed a Strategic Platform License with Adicet Bio - Yahoo Finance
2025-08-11 • Google News
MaxCyte, Inc. (MXCT) Reports Q2 Loss, Misses Revenue Estimates - Nasdaq
2025-08-06 • Google News